Why is Bal Pharma falling/rising?

As of 17-Oct, Bal Pharma Ltd's stock price is currently at Rs 80.20, reflecting a decline of Rs 1.25 or 1.53%. The stock has been underperforming recently, having fallen for the last three days and showing a total decline of 3.84% during this period. It is also trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Additionally, the stock is close to its 52-week low, being only 4.86% away from Rs 76.3. Over the past week, Bal Pharma has experienced a significant drop of 3.92%, and its year-to-date performance shows a steep decline of 34.40%, further highlighting its struggles compared to the benchmark Sensex, which has gained 7.44% in the same timeframe. Unfortunately, there is no information available regarding positive or negative factors that could influence the stock's recent movement. In the broader market context, Bal Pharma's recent performance contrasts sharply with the Sensex, which has shown a positive return of 1.76% over the past week and 1.52% over the past month. This divergence indicates that while the overall market is experiencing gains, Bal Pharma is lagging significantly behind, reflecting investor sentiment that may be cautious or negative towards the company. The rising investor participation, as evidenced by a 62.59% increase in delivery volume, suggests some interest in the stock; however, this has not translated into price appreciation, further emphasizing the stock's current downward trajectory amidst a generally positive market environment.